Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2000
08/10/2000WO2000046215A1 Benzazepine derivatives as alpha-v integrin receptor antagonists
08/10/2000WO2000046189A1 Sulfonamide derivatives having cyclic structures
08/10/2000WO2000046187A2 Antizyme modulators and their use
08/10/2000WO2000045853A2 Treatment of tumors with genetically engineered herpes virus
08/10/2000WO2000045852A1 Method of treating cancer by restoration of pp32 function
08/10/2000WO2000045851A2 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin
08/10/2000WO2000045849A2 Use of cationic lipids to generate anti-tumor immunity
08/10/2000WO2000045845A2 Liposome composition and method for administration of a radiosensitizer
08/10/2000WO2000045841A2 Human papilloma virus vaccine formulations
08/10/2000WO2000045838A1 A METHOD FOR TARGETED DEGRADATION OF INTRACELLULAR PROTEINS IN VIVO OR $i(EX VIVO)
08/10/2000WO2000045836A1 Uses of thank, a tnf homologue that activates apoptosis
08/10/2000WO2000045829A1 Brassica extracts or sulforaphane in combination with resveratrol as antitumor agents
08/10/2000WO2000045816A1 Calcilytic compounds
08/10/2000WO2000045814A1 Methods and compositions to enhance white blood cell count
08/10/2000WO2000045805A2 Methods of inhibiting the hgf-met-upa-plasmin network with geldanamycin derivates
08/10/2000WO2000045791A2 Method for controlling liposome size
08/10/2000WO2000033861A3 Pharmaceutical compositions containing protein-disulfide isomerases
08/10/2000WO2000028975A3 Improved chemical process and pharmaceutical formulation
08/10/2000WO2000027822A3 Tricyclic pyrazole derivatives
08/10/2000WO2000025827A3 Dna molecules encoding muc-1 and use thereof in tumor vaccination
08/10/2000WO2000024911A3 Human phospholipases
08/10/2000WO2000024360A3 Preparation and use of solidified oils
08/10/2000WO2000015206A3 Tryptophanyl ester and their n-acyl derivatives for the prevention and treatment of diseases caused or exacerbated by oxidation processes
08/10/2000WO2000010543A3 Medicament containing platinum complex compounds and the use thereof
08/10/2000WO2000004866A9 Preparation of thioarabinofuranosyl compounds and use thereof
08/10/2000DE19906159A1 16-Hydroxyestratriene als selektiv wirksame Estrogene 16-hydroxyestratrienes as selective estrogens effective
08/10/2000DE19904514A1 Antiviral agent, e.g. vaccine, antibody, agent that inhibits viral replication, transcription or translation, useful for preventing or treating tumors (or conditions which may become tumorous) associated with viral infections
08/10/2000CA2362259A1 Antizyme modulators and their use
08/10/2000CA2362230A1 Sulfamato hydroxamic acid metalloprotease inhibitor
08/10/2000CA2362126A1 B7rp-1 polypeptides
08/10/2000CA2361838A1 Method of treating cancer by restoration of pp32 function
08/10/2000CA2361589A1 Calcilytic compounds
08/10/2000CA2361551A1 Method for controlling liposome size
08/10/2000CA2361459A1 Use of cationic lipids to generate anti-tumor immunity
08/10/2000CA2360942A1 Preparations for preventing and/or treating a tissue change of mesenchymal origin
08/10/2000CA2360941A1 Liposome composition and method for administration of a radiosensitizer
08/10/2000CA2360741A1 Protein with cell proliferation and cell division modulating activity and dna encoding such protein
08/10/2000CA2360688A1 Human t cell effectors expressing cd86 molecule and therapeutic use thereof
08/10/2000CA2358855A1 Benzazepine derivatives as alpha-v integrin receptor antagonists
08/09/2000EP1026253A2 Expression of exogenous polynucleotide sequences in a vertebrate
08/09/2000EP1026244A1 Proteins Capable of Triggering G2/M transition and of Interacting with CDC2- and Cyclin B
08/09/2000EP1026165A1 O-substituted Hydroxycoumaranone derivatives as antitumor and antimetastatic agents
08/09/2000EP1025871A1 Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair
08/09/2000EP1025856A2 Methods for modulating T Cell unresponsiveness
08/09/2000EP1025237A2 Human checkpoint kinase, hcds1, compositions and methods
08/09/2000EP1025236A2 Human checkpoint kinase, hcds1, compositions and methods
08/09/2000EP1025228A1 Human tumor necrosis factor receptor-like proteins tr11, tr11sv1, and tr11sv2
08/09/2000EP1025223A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
08/09/2000EP1025212A2 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
08/09/2000EP1025124A1 Low-toxicity human interferon-alpha analogues
08/09/2000EP1025098A1 Benzothiophenes
08/09/2000EP1025096A1 Substituted chroman derivatives
08/09/2000EP1025094A1 Substituted indan derivatives
08/09/2000EP1025090A1 Vitronectin receptor antagonists
08/09/2000EP1025082A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments
08/09/2000EP1025077A1 Novel aryloxy-alkyl-dialkylamines
08/09/2000EP1024835A1 J-chain and analogues as epithelial cell targeting conjugates
08/09/2000EP1024815A1 Pharmaceutical compositions for oral administration of molecular iodine
08/09/2000EP1024801A2 Method for regulating size and growth of vascularized normal tissue
08/09/2000EP0862563B1 10-deacetyl-14beta-hydroxybaccatine iii derivatives, a process for the preparation thereof and formulations containing them
08/09/2000EP0642513B1 Indolocarbazole imides and their use
08/09/2000EP0629238B1 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
08/09/2000EP0568645B1 Mixed specificity fusion proteins
08/09/2000CN1262677A Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, noval compounds thereof and their use as chemotherapeutic agents
08/09/2000CN1262624A Use of colchinol derivatives as vascular damaging agents
08/09/2000CN1262267A 20 kinds of modified vitamin D series derivatives, preparing and drug thereof
08/09/2000CN1055292C Anti-hyperplasia and anti-inflammatory pentose monosaccharide derivative and medicinal composition containing same
08/09/2000CN1055235C Oral liquor for treatment of lung cancer and preparation method therefor
08/09/2000CN1055233C Medicine composition for curing digestive tracttumor and its preparing process
08/08/2000US6100411 Taxoid anti-tumor agents and pharmaceutical compositions thereof
08/08/2000US6100299 Tumor necrosis factor inhibitor; anticarcinogenic agents, antiinflammatory agents
08/08/2000US6100283 Prodrug phosphate derivative for poly (adp-ribose) polymerase enzyme inhibitor for administering in conjunction with antitumor drug or radiotherapy
08/08/2000US6100282 Thiazole derivatives
08/08/2000US6100273 Water soluble camptothecin derivatives
08/08/2000US6100271 Compounds which mediate intracellular signaling response to abnormal external stimuli characteristic of diseases; antiinflammatory agents, antifibrotic agents, antisclerotic agents, antitumor agents
08/08/2000US6100266 Hydroxamic and carboxylic acid derivatives
08/08/2000US6100248 By inhibiting cell proliferation, metastasis; administering 4-de(dimethylamino)tetracycline and specified derivatives; treating cancer of the prostate, breast, and colon, lung melanomas, and lymph cancer
08/08/2000US6100243 Method of sensitizing tumor cells with adenovirus E1A
08/08/2000US6100090 Compound 8 to 30 nucleobases in length targeted coding region of human phosphatidyl inositol 3'-kinase p85; therapy and diagnosis of diseases related hormone and growth factor receptors and oncogene products
08/08/2000US6100071 Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
08/08/2000US6100060 Recombinant expression system of polynucleotide encoding a specific amino acid sequence and present in a host cell; for recombinant production of wnt-5b polypeptides important in developmental signal transduction
08/08/2000US6100037 Polynucleotide encoding a cyclic nucleotide phosphodiesterase having a specific amino acid sequence; diagnosis, treatment, and prevention of cancer and immune disorders; anticarcinogenic/antidiabetic/antiarthritic agents
08/08/2000US6099848 Immunogenic compositions comprising DAL/DAT double-mutant, auxotrophic, attenuated strains of Listeria and their methods of use
08/08/2000US6099846 Immunocomplex; forming antibodies
08/08/2000US6099845 Process for the preparation of Rhus verniciflua extract and anti-cancer composition containing same
08/08/2000US6099823 Compositions and methods for the treatment and diagnosis of cardiovascular disease
08/08/2000US6099457 Endocurietherapy
08/08/2000CA2233144C Arf-p19, a novel regulator of the mammalian cell cycle
08/08/2000CA2188133C Tin-117m-containing radiotherapeutic agents
08/08/2000CA2185019C Isoxazoline compounds as inhibitors of tnf release
08/08/2000CA2177743C New alkoxy-aryl compounds, process for preparing the same and pharmaceutical compositions containing them
08/08/2000CA2002218C Neoglycoproteins, the preparation and use thereof
08/08/2000CA1341082C Method of treating tumor cells by inhibiting growth factor receptor function
08/03/2000WO2000045167A2 Non-invasive method for detecting target rna
08/03/2000WO2000044908A2 Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins
08/03/2000WO2000044900A2 Nucleic-acid binding proteins
08/03/2000WO2000044899A1 Her-2/neu fusion proteins
08/03/2000WO2000044897A1 Method of treating restenosis by antisense targeting of c-myc
08/03/2000WO2000044895A1 Method and medicament for inhibiting the expression of a defined gene
08/03/2000WO2000044894A1 Method for isolating apoptosis-inducing dna sequences and detection system
1 ... 1890 1891 1892 1893 1894 1895 1896 1897 1898 1899 1900 1901 1902 1903 1904 1905 1906 1907 1908 1909 1910 ... 2211